Birgitta Haga Gripsrud1, Kelly J Brassil, Barbara Summers, Håvard Søiland, Steven Kronowitz, Kirsten Lode. 1. Author Affiliations: Departments of Research (Drs Gripsrud and Lode) and Breast and Endocrine Surgery (Dr Søiland), Stavanger University Hospital, Stavanger; and Department of Clinical Science, University of Bergen, Bergen, Norway (Dr Søiland); Division of Nursing (Drs Brassil and Summers); and Department of Plastic Surgery (Dr Kronowitz), The University of Texas M. D. Anderson Cancer Center, Houston, Texas.
Abstract
BACKGROUND: Expressive writing has been shown to improve quality of life, fatigue, and posttraumatic stress among breast cancer patients across cultures. Understanding how and why the method may be beneficial to patients can increase awareness of the psychosocial impact of breast cancer and enhance interventional work within this population. Qualitative research on experiential aspects of interventions may inform the theoretical understanding and generate hypotheses for future studies. AIM: The aim of the study was to explore and describe the experience and feasibility of expressive writing among women with breast cancer following mastectomy and immediate or delayed reconstructive surgery. METHODS: Seven participants enrolled to undertake 4 episodes of expressive writing at home, with semistructured interviews conducted afterward and analyzed using experiential thematic analysis. RESULTS: Three themes emerged through analysis: writing as process, writing as therapeutic, and writing as a means to help others. CONCLUSIONS: Findings illuminate experiential variations in expressive writing and how storytelling encourages a release of cognitive and emotional strains, surrendering these to reside in the text. The method was said to process feelings and capture experiences tied to a new and overwhelming illness situation, as impressions became expressions through writing. Expressive writing, therefore, is a valuable tool for healthcare providers to introduce into the plan of care for patients with breast cancer and potentially other cancer patient groups. IMPLICATIONS FOR PRACTICE: This study augments existing evidence to support the appropriateness of expressive writing as an intervention after a breast cancer diagnosis. Further studies should evaluate its feasibility at different time points in survivorship.
BACKGROUND: Expressive writing has been shown to improve quality of life, fatigue, and posttraumatic stress among breast cancerpatients across cultures. Understanding how and why the method may be beneficial to patients can increase awareness of the psychosocial impact of breast cancer and enhance interventional work within this population. Qualitative research on experiential aspects of interventions may inform the theoretical understanding and generate hypotheses for future studies. AIM: The aim of the study was to explore and describe the experience and feasibility of expressive writing among women with breast cancer following mastectomy and immediate or delayed reconstructive surgery. METHODS: Seven participants enrolled to undertake 4 episodes of expressive writing at home, with semistructured interviews conducted afterward and analyzed using experiential thematic analysis. RESULTS: Three themes emerged through analysis: writing as process, writing as therapeutic, and writing as a means to help others. CONCLUSIONS: Findings illuminate experiential variations in expressive writing and how storytelling encourages a release of cognitive and emotional strains, surrendering these to reside in the text. The method was said to process feelings and capture experiences tied to a new and overwhelming illness situation, as impressions became expressions through writing. Expressive writing, therefore, is a valuable tool for healthcare providers to introduce into the plan of care for patients with breast cancer and potentially other cancerpatient groups. IMPLICATIONS FOR PRACTICE: This study augments existing evidence to support the appropriateness of expressive writing as an intervention after a breast cancer diagnosis. Further studies should evaluate its feasibility at different time points in survivorship.
Authors: Heidi E Koschwanez; Ngaire Kerse; Margot Darragh; Paul Jarrett; Roger J Booth; Elizabeth Broadbent Journal: Psychosom Med Date: 2013-06-26 Impact factor: 4.312
Authors: Erika A Henry; Rebecca J Schlegel; Amelia E Talley; Lisa A Molix; B Ann Bettencourt Journal: Oncol Nurs Forum Date: 2010-11 Impact factor: 2.172
Authors: M B Jensen-Johansen; S Christensen; H Valdimarsdottir; S Zakowski; A B Jensen; D H Bovbjerg; R Zachariae Journal: Psychooncology Date: 2012-09-19 Impact factor: 3.894